New algorithm significantly improves imaging for full-body MRIs

May 5, 2011

A new study reveals an improved algorithm that can dramatically improve how radiologists capture and interpret full-body MRIs, particularly in the abdominal region.

Motion artifacts in MRIs, such as patient movement, often appear as ghosting artifacts which may obscure clinical information says Dr. Candice Bookwalter, presenting author for the study. "Almost every acquisition during an MR abdominal exam requires a breath hold to limit motion. For example, a routine liver exam includes at least nine breath holds. Even with fast imaging techniques, these breath holds are often long and difficult for patients, and failed breath holds are almost always identified only after . This is particularly problematic in timed post-contrast imaging," she says.

She and her team developed the Motion Artifact Removal by Retrospective Resolution Reduction (MARs) to identify the transition between a breath hold and free breathing to allow for better retrospective reviews of the image and to reduce the need for additional imaging. Dr. Bookwalter says, "MARs detected and removed motion corrupted data automatically in our asymptomatic volunteers and patients, which improved the overall ."

In the study performed at the University Hospital at Case Medical Center, , Dr. Bookwalter and her colleagues successfully showed how the MARs technique allows radiologists and technicians to create clinically useful images, even in the presence of motion. She is confident that this algorithm will be useful tool for image interpretation. She says, "The MARs algorithm requires very little alteration of the clinical MR protocol. We envision the final application of this technique to be completely automatic and likely applied by the clinical technologist prior to presentation to the ."

Dr. Bookwalter will deliver a presentation on this study on Thursday, May 5, 2011 at the 2011 ARRS Annual Meeting at the Hyatt Regency Chicago.

Explore further: Improved protocols for contrast agents eliminates new cases of nephrogenic systemic fibrosis

Related Stories

Improved protocols for contrast agents eliminates new cases of nephrogenic systemic fibrosis

May 3, 2011
A recent study shows how one medical center implemented strict protocols for administering gadolinium-based contrast agents (GBCAs) before imaging and eliminated new cases for nephrogenic system fibrosis (NSF).

Study says eliminate pelvic imaging to reduce radiation for the detection of venous thromboembolism

May 3, 2011
A recent study shows that pelvic imaging using computed tomography (CT) examinations are not necessary for diagnosing patients with venous thromboembolism (VTE) and eliminating this exam can significantly reduce a patient's ...

Recommended for you

Physical activity could combat fatigue, cognitive decline in cancer survivors

July 25, 2017
A new study indicates that cancer patients and survivors have a ready weapon against fatigue and "chemo brain": a brisk walk.

Breaking the genetic resistance of lung cancer and melanoma

July 25, 2017
Researchers from Monash University and the Memorial Sloan Kettering Cancer Center (MSKCC, New York) have discovered why some cancers – particularly lung cancer and melanoma – are able to quickly develop deadly resistance ...

Anti-cancer chemotherapeutic agent inhibits glioblastoma growth and radiation resistance

July 24, 2017
Glioblastoma is a primary brain tumor with dismal survival rates, even after treatment with surgery, chemotherapy and radiation. A small subpopulation of tumor cells—glioma stem cells—is responsible for glioblastoma's ...

New therapeutic approach for difficult-to-treat subtype of ovarian cancer identified

July 24, 2017
A potential new therapeutic strategy for a difficult-to-treat form of ovarian cancer has been discovered by Wistar scientists. The findings were published online in Nature Cell Biology.

Immune cells the missing ingredient in new bladder cancer treatment

July 24, 2017
New research offers a possible explanation for why a new type of cancer treatment hasn't been working as expected against bladder cancer.

No dye: Cancer patients' gray hair darkened on immune drugs

July 21, 2017
Cancer patients' gray hair unexpectedly turned youthfully dark while taking novel drugs, and it has doctors scratching their heads.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.